检索

期
标题
作者
卷 10, 编号 6 (2024)
Atrial fibrillation: Controversial issues of modern classification, new possibilities of diagnostics and treatment
Tarzimanova A.
PDF
(Rus)
卷 10, 编号 4 (2024)
Correlation between low density lipoproteins / high density lipoproteins ratio and new-onset atrial fibrillation after coronary artery bypass grafting
Tatarintseva Z., Kosmachova E.
PDF
(Rus)
卷 9, 编号 8 (2023)
Correction of risk factors in patients with atrial fibrillation
Prekina V., Kunyaeva T., Shokina S., Samolkina O., Skopina Y.
PDF
(Rus)
卷 8, 编号 7 (2022)
Obesity and atrial fibrillation: mechanisms of occurence and current treatment guidelines
Tarzimanova A.
PDF
(Rus)
卷 9, 编号 7 (2023)
Impact of long-term antiarrhythmic therapy on the progression of atrial fibrillation from paroxysmal to permanent form
Tarzimanova A.
PDF
(Rus)
卷 10, 编号 6 (2024)
Hypokalemia in a patient with heart failure and atrial fibrillation as a predictor of life-threatening arrhythmia
Tatarintseva Z., Katushkina Y., Kosmacheva E., Babicheva O.
PDF
(Rus)
编号 3 (2018)
New possibilities for personalizing prognosis in patients with nonvalvular atrial fibrillation
Agibova N., Boeva O.
PDF
(Rus)
卷 8, 编号 9 (2022)
PREVENTION OF STROKE AND SYSTEMIC EMBOLISM IN PATIENTS WITH ATRIAL FIBRILLATION: FOCUS ON APIXABAN
Kokorin V., Boeva O.
PDF
(Rus)
卷 10, 编号 7 (2024)
Use of apixaban for prevention of a secondary brain stroke in patients with atrial fibrillation
Kasimova A., Tufanova O.
PDF
(Rus)
卷 9, 编号 5 (2023)
Prevention of gastrointestinal bleeding in patients with atrial fibrillation receiving oral anticoagulants: Whom? When? How?
Vorobyeva N., Malaya I., Alimova E., Tkacheva O.
PDF
(Rus)
编号 2 (2017)
Directly acting oral anticoagulants in the stroke prevention in patients with non-valvular atrial fibrillation and different concomitant diseases
Yavelov I.
PDF
(Rus)
卷 8, 编号 8 (2022)
Hyperthyroidism and atrial fibrillation: a tangle of interdisciplinary problems associated with COVID-19 pandemic
Ruyatkina L., Ruyatkin D.
PDF
(Rus)
卷 9, 编号 4 (2023)
Anticoagulant therapy for non-valvular atrial fibrillation patients with CHA2DS2-VASc (regardless of gender): a personalized approach based on risk/benefit analysis
Adasheva T., Samorukova E., Gubernatorova E., Lobanova E., Shakhrai N.
PDF
(Rus)
编号 2 (2017)
Atrial fibrillation and chronic kidney disease: correction of treatment
Melekhov A.
PDF
(Rus)
卷 8, 编号 5 (2022)
The significance of non-alcoholic fatty liver disease in atrial fibrillation development: view of cardiologist
Tarzimanova A.
PDF
(Rus)
编号 3 (2015)
NEW POSSIBILITIES OF PHARMACOLOGICAL CARDIOVERSION OF NEWLY DEVELOPED PAROXYSM OF ATRIAL FIBRILLATION
Cheltsov V., Guschina Y., Illarionova T., Korovyakova E., Martynov A.
PDF
(Rus)
卷 10, 编号 5 (2024)
Ischemic stroke in case of atrial fibrillation: influence of previous therapy at the early functional recovery of the patient
Geraskina L., Maksimova M., Fonyakin A., Garabova N., Burzhunova M.
PDF
(Rus)
卷 8, 编号 5 (2022)
JDP2 - a new promising biological marker in cardiovascular pathology
Alieva A., Reznik E., Teplova N., Totolyan G., Gasanova E., Kalova M., Sabanchieva E., Nikitin I.
PDF
(Rus)
卷 7, 编号 9 (2021)
Predicting the development of atrial fibrillation using multiple logistic regression
Nikulina S., Shishkova K., Chernova A., Schulman V.
PDF
(Rus)
编号 4S (2022): Supplement
Pharmacoeconomic evaluation of genotype-guided dabigatran etexilate dosing in patients with atrial fibrillation and chronic kidney disease
Mikhaylenko E., Tchubarev V., Abdullaev S., Skripka A., Sychev D.
PDF
(Rus)
卷 10, 编号 1 (2024)
Pharmacoeconomic analysis of apixaban use for secondary thromboprophylaxis at outpatient stage among oncological patients
Kasimova A., Kolbin A.
PDF
(Rus)
卷 7, 编号 7 (2021)
Thrombotic complications in patients with liver cirrosis: current state of the problem
Osadchuk A., Osadchuk M., Zolotovskaya I.
PDF
(Rus)
卷 8, 编号 9 (2022)
ATRIAL FIBRILLATION IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY: WHICH TACTICS IS OPTIMAL FOR RHYTHM CONTROL STRATEGY?
Kuznetsova M., Tarasov A., Vinuesa D., Sambrano V., Davtyan K., Drapkina O.
PDF
(Rus)
卷 7, 编号 5 (2021)
Management of elderly patients with nonvalvular atrial fibrillation: focus on «fragile» patients
Roytberg G., Slastnikova I., Sharkhun O.
PDF
(Rus)
卷 8, 编号 8 (2022)
Propafenone and sotalol use in the treatment of atrial fibrillation
Doshchitsin V., Syrov A.
PDF
(Rus)
1 - 25 的 25 信息

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回（例如，隐含AND）
  • 使用OR结合多个检索词，便于查找含有这些检索词的文章，例如education OR research
  • 使用括号来创建更复杂的查询; 例如：archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如： "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如：online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语